Wolfgang Künnecke
Chief Executive Officer at 908 Devices GmbH
Wolfgang Künnecke active positions
| Companies | Position | Start | End |
|---|---|---|---|
908 Devices GmbH
 908 Devices GmbH Medical SpecialtiesHealth Technology Part of 908 Devices, Inc., 908 Devices GmbH is a German company that manufactures and supplies analytical devices for biotechnology monitoring. The company is based in Braunschweig, Germany. The company was founded in 2003 by Wolfgang Künnecke. Wolfgang Künnecke has been the CEO since 2003. 908 Devices was acquired by 908 Devices, Inc. on August 09, 2022 for $17.68 million. | Chief Executive Officer | 2002-12-31 | - |
| Chairman | 2002-12-31 | - | |
| Founder | 2002-12-31 | - |
Career history of Wolfgang Künnecke
Former positions of Wolfgang Künnecke
| Companies | Position | Start | End |
|---|---|---|---|
| AUREUM REALWERT AG | Founder | 1991-11-17 | - |
| President | 1991-11-17 | - |
Statistics
International
| Germany | 3 |
Operational
| Founder | 2 |
| President | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Aureum Realwert AG
 Aureum Realwert AG Financial ConglomeratesFinance Aureum Realwert AG engages in the acquisition, administration and sale of financial assets such as investments in other companies. It invests in real assets including precious metals, raw materials, and real estate. The company was founded by Wolfgang Kuennecke on November 18, 1991 and is headquartered in Berlin, Germany. | Finance |
908 Devices GmbH
908 Devices GmbH Medical SpecialtiesHealth Technology Part of 908 Devices, Inc., 908 Devices GmbH is a German company that manufactures and supplies analytical devices for biotechnology monitoring. The company is based in Braunschweig, Germany. The company was founded in 2003 by Wolfgang Künnecke. Wolfgang Künnecke has been the CEO since 2003. 908 Devices was acquired by 908 Devices, Inc. on August 09, 2022 for $17.68 million. | Health Technology |
- Stock Market
- Insiders
- Wolfgang Künnecke
- Experience
